The actual wording of the Lipitor label (with link) follows. The label clearly states that LFT >3X ULN need to be discontinued (stopped – halted). RPRX LFT data stated it was >3X ULN, not below 3X ULN. A big difference. Far from reaching close to 5% with Proellex, the percent is 0.2%-0.6% for doses below the highest, which is 2.3% (80 mg).
You appear to be confusing when an individual patient should be halted and when an entire trial should be halted. ?
Market Data 
Markets 
AI
